Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

导出原文传递

翻译打印收藏纠错

作者： Park, Youngran ^[1] ; Chui, M. Herman ^[2] ; Rahmanto, Yohan Suryo ^[3] ; Yu, Zheng-Cheng ^[4] ; Shamanna, Raghavendra A. ; Bellani, Marina A. ; Gaillard, Stephanie ; Ayhan, Ayse ; Viswanathan, Akila ; Seidman, Michael M. ; Franco, Sonia ; Leung, Anthony K. L. ; Bohr, Vilhelm A. ; Shih, Ie-Ming ; Wang, Tian-Li

作者单位： Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA ^[1] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA ^[2] Johns Hopkins Univ, Sch Med, Dept Gynecol Obstet, Baltimore, MD USA ^[3] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA ^[4]

发布时间 2020-02-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical cancer research

2019年25卷18期

5584-5594页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除